Alison Siedor

ID: 1b83a05f-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Celltrion’s CT-P6 Demonstrates Equivalent Safety, Efficacy With HERCEPTIN

Big Molecule Watch · April 15, 2022

RELEUKO Receives FDA Approval

Big Molecule Watch · March 10, 2022

Innovent Announces Results of Phase III Trial of Sintilimab and Bevacizumab Combination Therapy In Patients With Advanced Lung Cancer

Big Molecule Watch · November 23, 2021

FDA Approves Interchangeable Status for BI’s Adalimumab Biosimilar Cyltezo

Big Molecule Watch · October 19, 2021